Stockreport

NGM Bio Reports Recent Highlights and First Quarter 2019 Financial Results

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report
PDF --Advanced NGM282 into Phase 2b ALPINE 2/3 clinical study in NASH-- --Received $177.8 million in aggregate net proceeds in April from Initial Public Offering and privat [Read more]